Health In Tech, Inc. (HIT)
NASDAQ: HIT · Real-Time Price · USD
1.580
-0.070 (-4.24%)
Apr 23, 2026, 11:59 AM EDT - Market open

Health In Tech Stock Forecast

Stock Price Forecast

The 2 analysts that cover Health In Tech stock have a consensus rating of "Strong Buy" and an average price target of $3.25, which forecasts a 105.70% increase in the stock price over the next year. The lowest target is $2.50 and the highest is $4.00.

Price Target: $3.25 (+105.70%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$2.50$3.25$4.00$4.00
Change+58.23%+105.70%+153.16%+153.16%

Analyst Ratings

The average analyst rating for Health In Tech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingFeb '26Mar '26Apr '26
Strong Buy112
Buy000
Hold000
Sell000
Strong Sell000
Total112

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Craig-Hallum
Craig-Hallum
Strong Buy
Initiates
$4
Strong BuyInitiates$4+153.16%Apr 20, 2026
Maxim Group
Maxim Group
Strong Buy
Initiates
$2.5
Strong BuyInitiates$2.5+58.23%Jun 26, 2025

Financial Forecast

Revenue This Year
46.99M
from 33.33M
Increased by 41.00%
Revenue Next Year
79.71M
from 46.99M
Increased by 69.63%
EPS This Year
-0.01
from 0.02
EPS Next Year
0.17
from -0.01
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
5.77M19.15M19.49M33.33M46.99M79.71M
Revenue Growth
-231.93%1.77%70.99%41.00%69.63%
EPS
0.000.050.010.02-0.010.17
EPS Growth
-2,788.89%-79.10%100.00%--
Forward PE
-----9.20
No. Analysts
----33
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027
High49.0M84.1M
Avg47.0M79.7M
Low45.5M76.2M

Revenue Growth

Revenue Growth20262027
High
47.0%
79.0%
Avg
41.0%
69.6%
Low
36.4%
62.1%

EPS Forecast

EPS20262027
High-0.18
Avg-0.010.17
Low-0.010.17

EPS Growth

EPS Growth20262027
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.